AGATA DRAPER: Open Payments
NPI 1265909709 · LINWOOD, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,395 in 195 payments from 20 companies in 2025. Trend: 2023 $2,264 · 2024 $3,093 · 2025 $3,395
Food & beverage: $3,212Education: $183
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 28 | $616 |
| ABBVIE INC. | 28 | $344 |
| UCB, Inc. | 15 | $336 |
| Organon LLC | 24 | $321 |
| Lilly USA, LLC | 14 | $247 |
| Regeneron Healthcare Solutions, Inc. | 7 | $224 |
| MAYNE PHARMA COMMERCIAL LLC | 12 | $210 |
| PFIZER INC. | 7 | $180 |
| LEO Pharma Inc. | 11 | $180 |
| E.R. Squibb & Sons, L.L.C. | 20 | $169 |
Products named: TREMFYA, Bimzelx, SKYRIZI, DUPIXENT, Sotyktu, VTAMA, ADBRY, EBGLYSS.
Industry payments across NJ — which companies pay providers there.
